Journal of Bacteriology, April 2001, p. 2560-2569, Vol. 183, No. 8
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.8.2560-2569.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Department of Clinical Bacteriology, Umeå University, S-901 85 Umeå, Sweden,1 and Centre de Génétique Moléculaire du CNRS, 91190 Gif-sur-Yvette, France2
Received 29 August 2000/Accepted 24 January 2001
| |
ABSTRACT |
|---|
|
|
|---|
The present study shows that active, self-splicing group II intron GBSi1 is located downstream of the C5a-peptidase gene, scpB, in some group B streptococcus (GBS) isolates that lack insertion sequence IS1548. IS1548 was previously reported to be often present at the scpB locus in GBS isolated in association with endocarditis. Since none of 67 GBS isolates examined, 40 of which were of serotype III, harbored both IS1548 and GBSi1, these two elements are suggested to be markers for different genetic lineages in GBS serotype III. The DNA region downstream of scpB in GBS isolates harboring either GBSi1, IS1548, or none of these mobile elements was found to encode the laminin binding protein, Lmb, which shows sequence similarities to a family of streptococcal adhesins. IS1548 is inserted 9 bp upstream of the putative promoter for lmb, while the insertion site for GBSi1 is located 88 bp further upstream. Sequences highly similar to GBSi1 exist also in Streptococcus pneumoniae. An inverted repeat sequence, with features typical of transcription terminators, was identified immediately upstream of the insertion site for the group II intron both in the GBS and S. pneumoniae sequences. This motif is suggested to constitute a target for the GBS intron as well as for rather closely related introns in Bacillus halodurans, Pseudomonas alcaligenes, and Pseudomonas putida. When transcripts containing the GBSi1 intron were incubated at high concentrations of ammonium and magnesium, a major product with the expected length and sequence for the ligated exons was generated. Unlike, however, all members of group II investigated so far, the excised intron was in linear, rather than in a branched (lariat), form.
| |
INTRODUCTION |
|---|
|
|
|---|
The genomes of most organisms, including humans, harbor mobile genetic elements (41, 54). These elements may be responsible for many important changes during the evolution of the genome. Examples of mobile elements in bacteria are the insertion sequences (IS), which can move (transpose) with the aid of an IS-encoded transposase. IS are small DNA segments, 800 to 2,500 bp, with a capacity to modify gene expression and promote genome rearrangements (22, 23, 32). The majority of IS have short terminal inverted repeats of 10 to 40 bp at the ends (32). These inverted repeats can act as substrates for homologous recombination (20). Horizontal transfer of IS between species has been anticipated to occur by autonomous extrachromosomal elements such as bacteriophages and plasmids with wide host ranges (32). That genomic regions are differently organized in separate strains of a bacterial species has been revealed by complete genomic sequencing of, for example, Helicobacter pylori (1). These variable genomic regions, which constitute a basis for genetic diversity, are often associated with IS and repeat sequences.
The group II introns, which transpose via an RNA intermediate, are another type of putatively mobile genetic elements that are found not only in bacteria but also in bacterium-derived chloroplasts as well as in fungal and plant mitochondria (18, 38). The mobile group II introns are transcribed from chromosome- or plasmid-located intervening sequences and can autocatalyze their excision from primary transcripts in a process resembling nuclear pre-mRNA splicing. Thus, the intron RNA acts as an enzyme, a ribozyme (reviewed by Michel et al. [38]). In addition, many of those introns encode a protein which can facilitate the ribozyme activity by means of its "maturase" function and which has catalytic activities of its own. Mobile group II introns can transpose to cognate alleles that lack the intron. The spliced RNA and the intron-encoded, translated protein form a ribonucleoprotein complex which cleaves the recipient DNA in a reverse splicing process called retrohoming. After this cleavage the intron RNA is transcribed to cDNA by a domain of the protein with reverse transcriptase (RT) activity and the intron DNA can insert at the new position (11). Transposition to another genomic site can also occur (51, 55), and a distinct retrotransposition mechanism for lactococcal group II intron Ll.LtrB has recently been described (12). Site-specific deletions in Saccharomyces cerevisiae have been seen as a result of the transposition of a group II intron to a new site, followed by homologous recombination between the two copies of the transposed intron (44). However, no duplication or deletion was seen as a result of the mobility of Ll.LtrB either in Lactococcus lactis or in Escherichia coli (11).
In a previous study we identified novel IS element IS1548 in Streptococcus agalactiae (group B streptococcus [GBS]) (21). Two out of a minimum of three copies of the element could be located in the genome. One copy was found inserted in the coding sequence of the hyaluronidase gene, and another copy was located downstream of the C5a-peptidase gene (scpB). The latter copy was present in all isolates harboring IS1548. When a collection of clinical GBS strains was examined, 69% of isolates from the blood of endocarditis patients contained IS1548 compared to 14% of vaginally colonizing isolates. A potential association between the occurrence of IS1548 and virulence properties of the GBS strains enabling them to cause endocarditis was speculated upon. GBS is a principal bacterial cause of neonatal mortality and morbidity in the United States and Europe, causing sepsis, respiratory distress, and meningitis. (3). However, in recent years an increasing incidence of invasive GBS disease among adults has been reported. This, together with invasive disease seen also in previously healthy individuals, has led to the suggestion of an increase in the virulence potential of the bacteria (15), possibly as a consequence of the emergence and spread of specially virulent clones (46).
In this paper, we document for the first time the presence of an active, self-splicing group II intron in the genus Streptococcus. The group II intron was found to be located downstream of the C5a-peptidase gene in GBS, and this region can also be an insertion site for IS1548. However, no GBS isolate in which both elements coexisted was found, which suggests that the two elements may be present in different phylogenetic lineages of GBS.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Bacterial strains and media. Fifty GBS of different serotypes isolated from adults were studied. Thirteen of those GBS isolates were from the blood of endocarditis patients, 15 were from the blood of bacteremic patients, and 22 were vaginally colonizing isolates, all isolated in Sweden. In addition, 17 serotype III isolates from the United States were examined. Six of these isolates, B1 to B5 and M732, were from infected newborns, and five were vaginally colonizing isolates from women who had given birth to healthy children. Isolates 3162, 3163, and 3165 were from "high-virulence" serotype III, electrophoretic type 1 (ET1), and isolates 3161, 3164, and 3166 were from "low-virulence" serotype III, ET12, as defined by Musser et al. (46). The streptococci were cultured on blood agar plates or in Todd-Hewitt broth (Difco, Detroit, Mich.) at 37°C.
PCR.
PCR was carried out with Taq polymerase from
MBI Fermenta (Gothenburg, Sweden) as previously described
(21). Primers used were based on the published sequences
of scpB (8), IS1548
(21), and sequences from this study (Table
1). The primers were purchased from DNA
Technology A/S (Aarhus, Denmark). Chromosomal DNA or a preparation from
5 to 10 bacterial colonies dissolved in 100 µl of sterile water and
incubated at 95°C for 10 min was used as the template in the
reactions. For PCR, samples were incubated for 1 min at 94°C,
followed by 30 cycles of 1 min at 94°C, 1 min at the annealing
temperature (49 to 59°C), and 2 min at 72°C. The reaction was
completed with 3 min at 72°C. PCR products were electrophoresed in
(0.7 to 1%) agarose gels for about 1.5 h at 80 V, stained with
ethidium bromide, and visualized with an UV transilluminator. Fragment
sizes were estimated by comparison to the Kilo Base DNA markers from
Pharmacia Biotech (Uppsala, Sweden). Chromosomal DNA was prepared as
described previously (7) with an additional step, which
consisted of treating the bacteria with 500 U of mutanolysin (Sigma)/ml
at 5 to 7°C for 18 h followed by incubation for 30 min at
37°C.
|
Southern blot hybridization. Chromosomal DNA was digested with HaeII (Boehringer Mannheim AB, Bromma, Sweden) for the identification of lmb and with EcoRI for the analysis of GBSi1. DNA was separated by 0.7% agarose gel electrophoresis and transferred to nylon filters (Hybond-N+; Amersham, Solna, Sweden) by use of a vacuum blotting system (VacuGene XL; Pharmacia) according to the manufacturer instructions. The probe used to localize the gene that subsequently was shown to be lmb was a PCR product amplified with primers scp3 from the 3' part of the C5a-peptidase gene, scpB, and hylislo from the 5' part of IS1548. The probe for analysis of the presence of GBSi1 was generated from the PCR amplificate of primers spafo1 and sparev2. The PCR products were purified with a High Pure PCR product purification kit (Boehringer Mannheim AB) and labeled with a DIG DNA labeling and detection kit (Boehringer Mannheim AB) in accordance with the protocol of the manufacturer. Hybridization and detection of the probe were performed according to Boehringer Mannheim AB recommendations at a hybridization temperature of 58°C. The length of the DNA fragment was compared to that of a DNA standard (Kilo Base DNA marker; Pharmacia Biotech) run in parallel.
DNA sequencing and nucleotide and amino acid sequence analysis. PCR products were purified with a High Pure PCR product purification kit (Boehringer GmbH) and sequenced using an ABI PRISM dye terminator cycle sequencing ready reaction kit (Perkin-Elmer, Norwalk, Conn.) according to the manufacturer instructions. The reactions were run on an ABI PRISM 377 DNA sequencer (Perkin-Elmer). Each strand was sequenced by a stepwise "walking strategy" using primers deduced from the preceding sequences. The list and sequences of the primers can be obtained upon request. The following primer pairs were used to generate the PCR products that were the templates for the first sequencing reactions (Table 1): scp3 and spacerev for GBSi1, scp3 and ann1rev for spacer in GBS isolate A5, and scp1 and scp2 (the latter located in IS1548) for spacer in isolate 5531. The sequencing of lmb in 5531 is described below. The resulting nucleotide sequences were aligned using the Genetics Computer Group program. Percentages of identity and similarities to nucleic and amino acid sequences were calculated by gapped BLAST at the National Center for Biotechnology Information (2). The deduced amino acid sequences were analyzed using the protein family alignments (Pfam) at the Sanger Centre (http: //www.sanger.ac.uk). Preliminary sequence data were obtained from The Institute for Genomic Research (TIGR) (http://www.tigr.org).
Inverse PCR. The lmb gene was identified by the use of inverse PCR. HaeII-digested chromosomal DNA from GBS isolate 5531 was separated by electrophoresis in an 0.7% agarose gel. The DNA fragments of appropriate length, according to Southern blot hybridization, were extracted using a Jet Quick gel extraction kit (Genomed, Bad Oeyenhausen, Germany) according to the manufacturer's protocol. The fragments were ligated with 6.2 U of T4 DNA ligase in ligation buffer with 1 mM ATP added (Pharmacia). Approximately 5 µg of DNA/ml was used, in a total volume of 20 µl. The solution was incubated for 3 h on ice, 2 h at room temperature, and 6 h at 10°C. Inverse PCR was performed using primers scp6 and hylisro. The PCR product was purified after gel electrophoresis and sequenced.
In vitro activity of the group II intron. The plasmid DNA (pGBSFL1) used as a template for in vitro transcription was a pUC119 derivative. The T7 promoter sequence, followed by the last 21 bases of the 5' exon, residues 1 to 383 and 1779 to 1857 of the intron, and the first 122 bases of the 3' exon, was inserted in front of the SacI site by standard procedures (50). The entire insert was verified by sequencing. After digestion with EcoRI and in vitro transcription in the presence of [32P]UTP, the resulting 616-base precursor molecule was gel purified as described by Costa et al. (10).
For in vitro self-splicing experiments, an aliquot of precursor transcript in water (final concentration, 10 nM) was preincubated for 2 min at the chosen temperature and then mixed with an equal volume of temperature-equilibrated 2×-concentrated splicing buffer. The splicing buffer contained magnesium and ammonium ions at various concentrations. During optimal reaction conditions the reaction mixture contained 40 mM Na-HEPES (pH 7.6 at 37°C), 1 M NH4Cl, 50 mM MgCl2, and 0.02% (wt/vol) sodium dodecyl sulfate. The reaction was stopped by addition of an equal volume of formamide-loading buffer (50) with Na2-EDTA at a concentration higher by 10 mM than that of magnesium. After electrophoresis of reacted samples on 4% polyacrylamide-8 M urea gels, autoradiographs were obtained and quantitated with a PhosphorImager (Molecular Dynamics). For characterization of the ligated exons and excised intron by reverse transcription, a preparative-scale splicing reaction mixture, for a reaction carried out under optimal conditions at 45°C, was electrophoresed on a 5% acrylamide-8 M urea gel. Products with the expected mobilities for the unreacted precursor, linear excised intron, and ligated exons were eluted from the gel, purified, and reverse transcribed with 32P-labeled primers as described by Costa et al. (10). Primer GBS1 (Table 1) is complementary to a sequence located downstream of the 5' intron-exon junction, whereas primer GBS2 is complementary to the 3' exon.Nucleotide sequence accession numbers. Sequence data from GBS isolates M732, 5531, and A5 have been submitted to the EMBL database under accession no. AJ292930, AJ290952, and AJ290953, respectively.
| |
RESULTS |
|---|
|
|
|---|
Identification of GBS group II intron GBSi1.
All previously
examined GBS isolates that harbored IS1548 had a copy of the
IS element downstream of the C5a-peptidase gene (scpB)
(21). This region was chosen for further examination and
was sequenced in three GBS isolates of serotype III. These were 5531, an endocarditis isolate harboring IS1548, and two isolates which lacked IS1548: M732, originally isolated from a
neonate with meningitis, and A5, a blood isolate from an adult. In 5531 the DNA sequence between scpB and the IS element was shown
to be a noncoding region of 158 bp denominated spacer. The
corresponding DNA sequence in A5 was indistinguishable from that of
spacer in 5531 (Fig. 1). However, when
spacer was sequenced in GBS isolate M732, it revealed an insertion of
1,857 bp. The inserted sequence was 92% identical to a sequence
located downstream of dexB (
1-6 glucosidase gene)
flanking the 5' capsule region in a serotype 19F isolate of
Streptococcus pneumoniae (9). A short stretch of nucleotides in the insert had 90% identity (38 of 42 bp) to an
H-repeat gene, which has features of IS elements (32) in E. coli. The G+C content of the insert in spacer was 45%.
|
|
-
' long-range pairing at the
expected location, are reminiscent of intron P1.LSU/2 and allies
(19). Since both these introns (and also the
Calothrix molecule [Fig. 2B]) belong to subgroup IIB
(38), GBSi1 is most likely a member of this subclass.
|
A putative target site motif for streptococcal group II
introns.
The insertion site of GBSi1 in spacer is preceded by an
inverted repeat region, 67 bp downstream from the 3' end of
scpB (Fig. 1). When the S. pneumoniae
serotype 4 nucleotide sequence at the ongoing sequencing project
presented at the TIGR website was searched, GBSi1-like sequences were
found. The homologies were consistent with two copies of the putative
group II intron, one copy at position 122378 in forward orientation and
the other at position 1994149 in the opposite direction. Southern blot
analysis of GBS isolates M732 and A15, which according to PCR analysis
harbored GBSi1, revealed two intron copies also in GBS (data not
shown). When the sequence upstream of the two putative pneumococcal
introns from the TIGR sequence and that of the S. pneumoniae
serotype 19F sequence were compared with the sequence upstream of
the GBSi1 insert in spacer, all four sequences were found to consist of an inverted repeat region followed by a poly(T) tail (Fig.
4). We have also noted the presence of
this motif upstream of group II intron sequences in Bacillus
halodurans, Pseudomonas alcaligenes, and Pseudomonas
putida (Fig. 4). Interestingly, these introns and the S. pneumoniae 19F sequence belong to a distinct branch in the group
II phylogenetic tree that was recently proposed by Martinez-Abarca and
Toro (35) based on an alignment of RT domains. See Fig. 2A
for comparison between the RT of GBSi1 and those of B. halodurans and P. alcaligenes. Moreover, in all members
of this subgroup, domain V has only 30 nucleotides (Fig. 3) and its first 2 bp are C1:G30 and C2:G29 (rather than R:Y and A:U, as in most
other group II introns).
|
Distribution of IS1548 and GBSi1 in GBS isolates.
Seventeen of 67 GBS isolates were previously shown to harbor IS element
IS1548 (21). The 67 isolates were examined by
PCR to reveal the distribution of the group II intron. The GBSi1 intron was found in 26 isolates of serotypes II, III, and V (Table
2). None of the isolates that harbored
GBSi1 was shown to contain IS1548. In order to test if this
mutually exclusive distribution extended to other insertion sequences,
the presence of IS861 among the isolates was determined. A
PCR product of about 1,200 bp indicated the presence of
IS861 in 34 isolates, distributed among all serotypes except
the single serotype IV strain of this study (Table 2). All isolates
containing IS1548 also harbored IS861, and
IS861 was found in several isolates where the intron was
present. In 15 of the 67 isolates none of the three elements could be
identified. The mutually exclusive distribution of IS1548
and GBSi1 was observed in both the Swedish and the American isolates.
The latter included three ET1 and ET12 serotype III isolates, defined
by Musser et al. to belong to high-virulence and low-virulence
subpopulations respectively (46). The high-virulence
subpopulation contained GBSi1, whereas the low-virulence group of
isolates harbored IS1548 (Table 2).
|
DNA sequence downstream of a copy of IS1548 located in
the scpB region.
The region downstream of the copy of
IS1548 located in the scpB region in endocarditis
isolate 5531 was sequenced. The DNA sequence revealed the presence of
lipoprotein-encoding gene lmb and a gene with unknown
function, called orfY, located downstream of lmb
(53). The amino acid sequence deduced from lmb
had similarities with AdcA in S. pneumoniae (35% identity
over 303 amino acids) in addition to other members of a solute
binding family of putative adhesive proteins represented by, for
example, FimA in Streptococcus parasanguis, PsaA in S. pneumoniae, and ScaA in Streptococcus gordonii
(53). Furthermore, the lmb nucleotide sequence
was almost identical (96%) to the incomplete sequence of 450 bp called orf3 located downstream of scpA in
group A streptococcus M-type 49 (47). The lmb
gene was present in all isolates examined including GBS isolates M732,
harboring GBSi1 but not IS1548, and A5, which lacked both
GBSi1 and IS1548 (Fig. 1). The DNA sequence of GBS 5531 revealed that in this endocarditis isolate IS1548 was
inserted 9 bp from the putative
35 promoter of lmb. The
GBSi1 insertion in spacer in the M732 isolate from a neonate with
meningitis was located 88 bp further upstream (Fig. 1).
In vitro self-splicing activity of the GBSi1 intron.
Since the
self-splicing activity of in vitro-synthesized group II intron
transcripts is generally unaffected, or even increased, by deletion of
the terminal loop of domain IV (reviewed by Michel and Ferat [37]),
the size of this loop was reduced from 1403 to 8 residues (resulting in
a 462-nucleotide intron) in the construct we used to test for in vitro
self-splicing (see Materials and Methods). When a purified
intron-containing transcript was incubated at 45°C in the presence of
elevated concentrations of ammonium and magnesium ions, two major
products with the expected electrophoretic mobilities for the ligated
exons and linear intron were generated by a rather slow reaction which
consumed about half of the precursor molecules in 2 h (Fig.
5A; experimental conditions were about optimal in terms of yield of the major products). The identity of the
gel-eluted products was confirmed by sequencing them with an RT. The
sequence of the excised intron (Fig. 5B) could be read almost all the
way to the final stop, which coincided with the intron-5' exon
junction. Despite repeated attempts at reverse transcription with a
primer complementary to the 3' exon, the ligated exons yielded only
rather low-quality sequencing lanes (Fig. 5C). As expected, the
sequence remained compatible with that of the precursor transcript all
the way to the 3' splice site and then diverged from it, but reading
was not possible over the entire length of the molecule. Nevertheless,
elongation could be shown to stop at precisely the expected site, 21 nucleotides upstream of the ligation junction (Fig. 5C).
|
39 to
9 (see above and
Discussion) does not improve the efficiency of the splicing reaction.
| |
DISCUSSION |
|---|
|
|
|---|
Group II intron GBSi1 identified in GBS. This work presents a previously undescribed group II intron in GBS. There has been a substantial increase in the number of group II introns from different bacterial genera reported since the first description of group II introns in bacteria in 1993 (17, 18, 28, 34, 39, 45, 49, 52, 56). However, information about their distribution among bacterial populations, the impact of the bacterial introns on the functionality of the genome, and the insertion sites of the introns is limited. Among the few gram-positive species in which group II introns have been described are Clostridium difficile, L. lactis, and Bacillus megaterium (25, 39, 45, 52). The identification of GBSi1 and the related putative group II introns in S. pneumoniae extends the presence of group II introns to the clinically important genus Streptococcus.
Mobility of group II introns was first shown in introns of the yeast Saccharomyces cerevisiae mitochondrial cytochrome oxidase genes (cox) (31, 43). The two cox1 introns ail and ai2 are the best-characterized mobile group II introns. They have a long ORF encoding a protein with RT (27) and maturase characteristics (42). The organization of group II introns is conserved throughout the eukaryotic and prokaryotic kingdoms. Regardless of their origin, their RNA can be folded into a conserved structure composed of six secondary structure domains radiating from a central wheel. When an ORF encoding a maturase and/or is present, it is located in domain IV (38). These characteristics are present in GBSi1, which has many other features of a bona fide group II intron, such as sequences nearly identical to the consensus at the 5' and 3' extremities, a bulging A on the 3' side of domain VI, and EBS1-IBS1 and
-
' potential long-range pairings
(Fig. 3). At the same time, the GBSi1 ribozyme is somewhat divergent
from most of its group II counterparts: the EBS2-IBS2 pairing appears
to be missing and the highly conserved domain V is lacking 2 bp. Because one trivial explanation for those unusual features would be
that the GBSi1 insert is a defective copy of a previously active transposable element, we attempted to rule out this interpretation by
investigating the capacity of GBSi1-containing transcripts to
self-splice in vitro.
While the ability to perform self-splicing is necessary both for the
excision and transposition of group II introns, the splicing reaction
has been shown to be facilitated by the intron-encoded protein
(36); in the absence of this product, most "active" group II introns perform rather sluggishly in vitro, even at elevated magnesium and monovalent ion concentrations (37). The
rather slow kinetics of the reaction shown in Fig. 5 thus provide no indication that the GBSi1 molecule has become freed from selective pressure for optimal function in vivo. On the other hand, the absence
of a lariat product, which is so far unique for a naturally occurring
member of group II, is all the more surprising in that the bulging A,
whose 2'-OH group is responsible for branch formation in other group II
introns, is definitely present at the expected location on the 3' side
of domain VI (Fig. 3). One possibility worth investigating would be
that, for GBSi1, the intron-encoded protein is necessary to initiate
splicing by transesterification.
Identification of a putative group II intron target site
motif.
A model for the retrohoming process in bacteria has been
suggested by Cousineau et al. based on the mobility of L. lactis group II intron LlLtrB (11). The intron RNA
and the intron-encoded protein form a combined RNA-protein complex
acting in consert to cleave the recipient DNA. The RNA catalyzes the
cleavage of the sense strand at the intron insertion site, and the
protein cleaves the antisense strand at position +9 from the insertion site (36). A cDNA copy generated by reverse transcription
is then incorporated into the recipient DNA (11). The
retrohoming in L. lactis is independent of extensive
homologous recombination and of recA. However, about 40 to
50 nucleotides are required for the ribonucleoprotein recognition of
the insertion site, and efficient retrotransposition requires at least
25 nucleotides upstream and downstream of the insertion site
(11). The intron RNA base pairs with nucleotides
13 to
+1 at the intron binding sites, (IBSs), whereas the protein recognizes
the nucleotide sequence from
25 to
13 and +2 to +25 counting from
the intron insertion site. The sequences upstream of the insertion site
of GBSi1, of the putative group II introns in S. pneumoniae,
and of the group II introns of branch 3 as described by
Martínez-Abarca and Toro (35) were found to have a
common theme. Each sequence contains a region of 29 to 39 nucleotides,
upstream of the first guanidine of the intron, composed of an inverted
repeat sequence followed by a poly(T) tail, a combination that is
common in bacterial transcription termination sites. High target
specificity is important for the retrohoming of group II introns
(30, 37). It seems likely that the inverted repeat region
serves as a motif that, by adding to the specificity of recognition
between the streptococcal group II introns and their target sites,
compensates for the absence of the EBS2-IBS2 pairing. A similar
recognition pattern for the integrases of other mobile elements has
been described. In phage lambda, the integrase recognizes approximately
30 bases made up of a pair of imperfect inverted repeats in the
recombination sites (6).
The presence of GBSi1 and IS1548 in GBS isolates is mutually exclusive. When 40 GBS isolates of serotype III were analyzed, it was found that 20 isolates harbored GBSi1 and 17 contained IS1548 but that in none of the isolates were both elements present. Several studies of GBS populations support a basically clonal distribution of isolates (24, 46, 48). Hauge et al. revealed six major lineages in the GBS population by combining electrophoretic analysis of multilocus enzymes with several other tests, among which was an assay for hyaluronidase activity (24). This and other studies have demonstrated that GBS type III isolates belong to two major, distantly related evolutionary lineages (24, 46, 48). One of the two major lineages among type III isolates of GBS found by Hauge et al. exhibited a hyaluronidase-negative phenotype (24). This genetic lineage of GBS included the three ET12 isolates examined in this study, originally defined by Musser et al. as a low-virulence subpopulation of GBS (46). Serotype III isolates that harbor IS1548, including these three ET12 strains, have an insertional mutation in the hyaluronidase gene and lack hyaluronidase activity (21). GBSi1 could possibly constitute a marker for the other major lineage of serotype III isolates. In favor of this hypothesis is the fact that, besides the mutual exclusiveness of IS1548 and GBSi1 among the isolates, the three ET1 isolates that previously had been assigned to the second major lineage of GBS type III (24, 46) all contained GBSi1.
No association between the existence of GBSi1 and another putative mobile element was found in the GBS isolates. This is in contrast to many other bacterial group II introns, which reside in transposable elements. In C. difficile the group II intron is located in conjugative transposon Tn5397 of the Tn916 family (45). The group II introns in E. coli and Shigella flexneri reside in IS or IS-like elements, and one group II intron from L. lactis is found on a conjugative plasmid (17, 39, 49). It has been suggested that other mobile genetic elements may act as carriers of bacterial group II introns (17, 34). Lactococcal group II intron Ll.LtrB has successfully been transferred via a plasmid both to L. lactis and to E. coli (11). However, there are non-long terminal repeat retrotransposable elements other than the group II introns that seem to be acquired only by virtue of vertical descent and thus are ancient participants in the host genome (33). Whether the group II introns in GBS are subject to horizontal transfer or mainly are vertically transmitted is not known. One possibility is that the genetic background of the strains interferes with the ability to harbor both IS1548 and GBSi1 in the same isolate. Interference between the target sites of the two elements would constitute a plausible explanation for mutual exclusion. IS1548 and GBSi1 both have a target site in the spacer region downstream of scpB. However, their sites of insertion are located 88 bp apart, and the presence of either element in the spacer sequence causes no apparent alteration to the presumed target sequence of the other element. To ascertain whether such interactions exist, further experimental work is needed. Another conceivable interaction between the elements could result from GBSi1 and IS1548 being harbored by yet-unidentified bacteriophages or transposons with immunity against the presence of the other element in the genome.Different positioning of IS1548 and GBSi1 in relation to the downstream-located lmb gene. Downstream of the spacer region among GBS isolates harboring either GBSi1, IS1548, or neither of the elements was gene lmb, previously defined as encoding a laminin binding protein (53). Interestingly in view of the suggested association of IS1548-harboring isolates with endocarditis, lmb is similar to a family of streptococcal lipoprotein adhesins including FimA and PsaA. FimA of Streptococcus parasanguis (16) has been associated with the colonization of damaged heart tissue in an endocarditis rat model (5). S. pneumoniae psaA mutants have been shown to display both reduced adherence to the A-549 lung epithelial cell line and reduced virulence in mice (4). The proteins in this family appear to be both adhesins and part of ATP-binding cassette (ABC) transporters for metal cations (13, 29). Recent data have also linked these ABC transporters to competence for genetic transformation in S. pneumoniae and S. gordonii (13, 14, 29).
It remains to show whether Lmb has any additional substrate-binding capacities besides the ability to bind laminin and to elucidate the possible implications of this protein for the pathogenesis of GBS endocarditis. In this context it will also be important to investigate whether the different positionings of IS1548 and GBSi1 with respect to the tentative lmb promoter affect transcription and hence possibly also the pathogenicity of the isolates.| |
ACKNOWLEDGMENTS |
|---|
We gratefully acknowledge the technical assistance of H. Edebro and A. Contardo.
This work was supported by The Swedish Medical Research Council (08675), Umeå University Insamlings fonden, The Wiberg Foundation, The Bergvall Foundation, The Sven Jerring Foundation, The Swedish Medical Society, and The Oscar foundation (to M.N.) and The Swedish Society for Medical Research and The Kempe Foundation (to M.G.).
Preliminary sequence data were obtained from the TIGR website at http://www.tigr.org.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Clinical Bacteriology, Umeå University, S-901 85 Umeå, Sweden. Phone: 46-90-7851772. Fax: 46-90-7852225. E-mail: Margareta.Granlund{at}climi.umu.se.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Alm, R. A., and T. J. Trust. 1999. Analysis of the genetic diversity of Helicobacter pylori: the tale of two genomes. J. Mol. Med. 77:834-846[CrossRef][Medline]. |
| 2. |
Altschul, S. F.,
T. L. Madden,
A. A. Schaffer,
J. Zhang,
Z. Zhang,
W. Miller, and D. J. Lipman.
1997.
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
Nucleic Acids Res.
25:3389-3402 |
| 3. | Baker, C. J. 1980. Group B streptococcal infections. Adv. Intern. Med. 25:475-501[Medline]. |
| 4. | Berry, A. M., and J. C. Paton. 1996. Sequence heterogeneity of PsaA, a 37-kilodalton putative adhesin essential for virulence of Streptococcus pneumoniae. Infect. Immun. 64:5355-5362. |
| 5. | Burnette-Curley, D., V. Wells, H. Viscount, C. L. Munro, J. C. Fenno, P. Fives-Taylor, and F. L. Macrina. 1995. FimA, a major virulence factor associated with Streptococcus parasanguis endocarditis. Infect. Immun. 63:4669-4674[Abstract]. |
| 6. |
Campbell, A. M.
1992.
Chromosomal insertion sites for phages and plasmids.
J. Bacteriol.
174:7495-7499 |
| 7. | Chassy, B. M. 1976. A gentle method for the lysis of oral streptococci. Biochem. Biophys. Res. Commun. 68:603-608[CrossRef][Medline]. |
| 8. | Chmouryguina, I., A. Suvorov, P. Ferrieri, and P. P. Cleary. 1996. Conservation of the C5a peptidase genes in group A and B streptococci. Infect. Immun. 64:2387-2390[Abstract]. |
| 9. | Coffey, T. J., M. C. Enright, M. Daniels, J. K. Morona, R. Morona, W. Hryniewicz, J. C. Patton, and B. G. Spratt. 1998. Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae. Mol. Microbiol. 27:73-83[CrossRef][Medline]. |
| 10. | Costa, M., J.-M. Fontaine, S. Loiseaux-de Goër, and F. Michel. 1997. A group II self-splicing intron from the brown alga Pylaiella littoralis is active at unusually low magnesium concentrations and forms populations of molecules with a uniform conformation. J. Mol. Biol. 274:353-364[CrossRef][Medline]. |
| 11. | Cousineau, B., D. Smith, S. Lawrence-Cavanagh, J. E. Mueller, J. Yang, D. Mills, D. Manias, G. Dunny, A. M. Lambowitz, and M. Belfort. 1998. Retrohoming of a bacterial group II intron: mobility via complete reverse splicing, independent of homologous DNA recombination. Cell 94:451-462[CrossRef][Medline]. |
| 12. | Cousineau, B., S. Lawrence, D. Smith, and M. Belfort. 2000. Retrotransposition of a bacterial group II intron. Nature 404:1018-1021[CrossRef][Medline]. |
| 13. | Dintilhac, A., G. Alloing, C. Granadel, and J. P. Claverys. 1997. Competence and virulence of Streptococcus pneumoniae: Adc and PsaA mutants exhibit a requirement for Zn and Mn resulting from inactivation of putative ABC metal permeases. Mol. Microbiol. 25:727-739[CrossRef][Medline]. |
| 14. | Dintilhac, A., and J. P. Claverys. 1997. The adc locus, which affects competence for genetic transformation in Streptococcus pneumoniae, encodes an ABC transporter with a putative lipoprotein homologous to a family of streptococcal adhesins. Res. Microbiol. 148:119-131[Medline]. |
| 15. | Eykyn, S. J., S. E. J. Young, and B. D. Coolson. 1991. Increased community-acquired septicaemic infection with group B streptococci in adults. Lancet 338:446. |
| 16. | Fenno, J. C., A. Shaikh, G. Spatafora, and P. Fives-Taylor. 1995. The fimA locus of Streptococcus parasanguis encodes an ATP-binding membrane transport system. Mol. Microbiol. 15:849-863[CrossRef][Medline]. |
| 17. | Ferat, J. L., M. Le Gouar, and F. Michel. 1994. Multiple group II self-splicing introns in mobile DNA from Escherichia coli. C. R. Acad. Sci. Ser. III 317:141-148[Medline]. |
| 18. | Ferat, J.-L., and F. Michel. 1993. Group II self-splicing introns in bacteria. Nature 364:358-364[CrossRef][Medline]. |
| 19. | Fontaine, J.-M., S. Rousvoal, C. Leblanc, B. Kloareg, and S. Loiseaux-de-Goër. 1995. The mitochondrial LSU rDNA of the brown alga Pylaiella littoralis reveals alpha-proteobacterial features and is split by four group IIB introns with an atypical phylogeny. J. Mol. Biol. 251:378-389[CrossRef][Medline]. |
| 20. | Galas, D. J., and M. Chandler. 1989. Bacterial insertion sequences, p. 109-162. In D. E. Berg, and M. M. Howe (ed.), Mobile DNA. American Society for Microbiology, Washington, D.C. |
| 21. | Granlund, M., L. Öberg, M. Sellin, and M. Norgren. 1998. Identification of a novel insertion element, IS1548, in group B streptococci, predominantly in strains causing endocarditis. J. Infect. Dis. 177:967-976[Medline]. |
| 22. | Gustafson, C. E., S. Chu, and T. J. Trust. 1994. Mutagenesis of the paracrystalline surface protein array of Aeromonas salmonicida by endogenous insertion elements. J. Mol. Biol. 237:452-463[CrossRef][Medline]. |
| 23. | Haack, K. R., and J. R. Roth. 1995. Recombination between chromosomal IS200 elements supports frequent duplication formation in Salmonella typhimurium. Genetics 141:1245-1252[Abstract]. |
| 24. | Hauge, M., C. Jespersgaard, K. Poulsen, and M. Kilian. 1996. Population structure of Streptococcus agalactiae reveals an association between specific evolutionary lineages and putative virulence factors but not disease. Infect. Immun. 64:919-925[Abstract]. |
| 25. | Huang, C. C., M. Narita, T. Yamagata, Y. Itoh, and G. Endo. 1999. Structure analysis of a class II transposon encoding the mercury resistance of the gram positive bacterium Bacillus megaterium MB1, a strain isolated from Minamata Bay, Japan. Gene 234:361-369[CrossRef][Medline]. |
| 26. |
Jarrell, K. A.,
C. L. Peebles,
R. C. Dietrich,
S. L. Romiti, and P. S. Perlman.
1988.
Group II intron self-splicing. Alternative reaction conditions yield novel products.
J. Biol. Chem.
263:3432-3439 |
| 27. | Kennell, J. C., J. V. Moran, P. S. Perlman, R. A. Butow, and A. M. Lambowitz. 1993. Reverse transcriptase activity associated with maturase-encoding group II introns in yeast mitochondria. Cell 73:133-146[CrossRef][Medline]. |
| 28. |
Knoop, V., and A. Brennicke.
1994.
Evidence for a group II intron in Escherichia coli inserted into a highly conserved reading frame associated with mobile DNA sequences.
Nucleic Acids Res.
22:1167-1171 |
| 29. |
Kolenbrander, P. E.,
R. N. Andersen,
R. A. Baker, and H. F. Jenkinson.
1998.
The adhesion-associated sca operon in Streptococcus gordonii encodes an inducible high-affinity ABC transporter for Mn2+ uptake.
J. Bacteriol.
180:290-295 |
| 30. | Lambowitz, A. M., and M. Belfort. 1993. Introns as mobile genetic elements. Annu. Rev. Biochem. 62:587-622[CrossRef][Medline]. |
| 31. | Lazowska, J., B. Meunier, and C. Macadre. 1994. Homing of a group II intron in yeast mitochondrial DNA is accompanied by unidirectional co-conversion of upstream-located markers. EMBO J. 13:4963-4972[Medline]. |
| 32. |
Mahillon, J., and M. Chandler.
1998.
Insertion sequences.
Microbiol. Mol. Biol. Rev.
62:725-774 |
| 33. | Malik, H. S., W. D. Burke, and T. H. Eickbush. 1999. The age and evolution of non-LTR retrotransposable elements. Mol. Biol. Evol. 16:793-805[Abstract]. |
| 34. | Martínez-Abarca, F., S. Zekri, and N. Toro. 1998. Characterization and splicing in vivo of a Sinorhizobium meliloti group II intron associated with particular insertion sequences of the IS630-Tc1/IS3 retroposon superfamily. Mol. Microbiol. 28:1295-1306[CrossRef][Medline]. |
| 35. | Martínez-Abarca, F., and N. Toro. 2000. Group II introns in the bacterial world. Mol. Microbiol. 38:917-926[CrossRef][Medline]. |
| 36. |
Matsuura, M.,
R. Saldanha,
H. Ma,
H. Wank,
J. Yang,
G. Mohr,
S. Cavanagh,
G. M. Dunny,
M. Belfort, and A. M. Lambowitz.
1997.
A bacterial group II intron encoding reverse transcriptase, maturase, and DNA endonuclease activities: biochemical demonstration of maturase activity and insertion of new genetic information within the intron.
Genes Dev.
11:2910-2924 |
| 37. | Michel, F., and J. L. Ferat. 1995. Structure and activities of group II introns. Annu. Rev. Biochem. 64:435-461[CrossRef][Medline]. |
| 38. |
Michel, F.,
K. Umesono, and H. Ozeki.
1989.
Comparative and functional anatomy of group II catalytic introns a review.
Gene
82:5-30[CrossRef][Medline].
|
| 39. |
Mills, D. A.,
L. L. McKay, and G. M. Dunny.
1996.
Splicing of a group II intron involved in the conjugative transfer of pRS01 in lactococci.
J. Bacteriol.
178:3531-3538 |
| 40. |
Mohr, G.,
P. S. Perlman, and A. M. Lambowitz.
1993.
Evolutionary relationships among group II intron-encoded proteins and identification of a conserved domain that may be related to maturase function.
Nucleic Acids Res.
21:4991-4997 |
| 41. |
Moran, J. V.,
R. J. DeBerardinis, and H. H. Kazazian, Jr.
1999.
Exon shuffling by L1 retrotransposition.
Science
283:1530-1534 |
| 42. |
Moran, J. V.,
K. L. Mecklenburg,
P. Sass,
S. M. Belcher,
D. Mahnke,
A. Lewin, and P. Perlman.
1994.
Splicing defective mutants of the COXI gene of yeast mitochondrial DNA: initial definition of the maturase domain of the group II intron aI2.
Nucleic Acids Res.
22:2057-2064 |
| 43. | Moran, J. V., S. Zimmerly, R. Eskes, J. C. Kennell, A. M. Lambowitz, R. A. Butow, and P. S. Perlman. 1995. Mobile group II introns of yeast mitochondrial DNA are novel site-specific retroelements. Mol. Cell. Biol. 15:2828-2838[Abstract]. |
| 44. | Mueller, M. W., M. Allmaier, R. Eskes, and R. J. Schweyen. 1993. Transposition of group II intron aI1 in yeast and invasion of mitochondrial genes at new locations. Nature 366:174-176[CrossRef][Medline]. |
| 45. | Mullany, P., M. Pallen, M. Wilks, J. R. Stephen, and S. Tabaqchali. 1996. A group II intron in a conjugative transposon from the gram-positive bacterium, Clostridium difficile. Gene 174:145-150[CrossRef][Medline]. |
| 46. |
Musser, J. M.,
S. J. Mattingly,
R. Quentin,
A. Goudeau, and R. K. Selander.
1989.
Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease.
Proc. Natl. Acad. Sci. USA
86:4731-4735 |
| 47. | Podbielski, A., M. Woischnik, B. Pohl, and K. H. Schmidt. 1996. What is the size of the group A streptococcal vir regulon? The Mga regulator affects expression of secreted and surface virulence factors. Med. Microbiol. Immunol. 185:171-181[CrossRef][Medline]. |
| 48. | Quentin, R., H. Huet, F. S. Wang, P. Geslin, A. Goudeau, and R. K. Selander. 1995. Characterization of Streptococcus agalactiae strains by multilocus enzyme genotype and serotype: identification of multiple virulent clone families that cause invasive neonatal disease. J. Clin. Microbiol. 33:2576-2581[Abstract]. |
| 49. | Rajakumar, K., C. Sasakawa, and B. Adler. 1997. Use of a novel approach, termed island probing, identifies the Shigella flexneri she pathogenicity island which encodes a homolog of the immunoglobulin A protease-like family of proteins. Infect. Immun. 65:4606-4614[Abstract]. |
| 50. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 51. | Sellem, C. H., G. Lecellier, and L. Belcour. 1993. Transposition of a group II intron. Nature 366:176-178[CrossRef][Medline]. |
| 52. | Shearman, C., J. J. Godon, and M. Gasson. 1996. Splicing of a group II intron in a functional transfer gene of Lactococcus lactis. Mol. Microbiol. 21:45-53[CrossRef][Medline]. |
| 53. |
Spellerberg, B.,
E. Rozdzinski,
S. Martin,
J. Weber-Heynemann,
N. Schnitzler,
R. Lütticken, and A. Podbielski.
1999.
Lmb, a protein with similarities to the LraI adhesin family, mediates attachment of Streptococcus agalactiae to human laminin.
Infect. Immun.
67:871-878 |
| 54. | Xiong, Y., and T. H. Eickbush. 1990. Origin and evolution of retroelements based upon their reverse transcriptase sequences. EMBO J. 9:3353-3362[Medline]. |
| 55. | Yang, J., S. Zimmerly, P. S. Perlman, and A. M. Lambowitz. 1996. Efficient integration of an intron RNA into double-stranded DNA by reverse splicing. Nature 381:332-335[CrossRef][Medline]. |
| 56. | Yeo, C. C., J. M. Tham, M. W. Yap, and C. L. Poh. 1997. Group II intron from Pseudomonas alcaligenes NCIB 9867 (P25X): entrapment in plasmid RP4 and sequence analysis. Microbiology 143:2833-2840[Abstract]. |
This article has been cited by other articles:
| ||||||||||